Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.36 |
| ▸ | CA2 | P00918 | 3/20 | 0.36 |
| ▸ | CA12 | O43570 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | DPP4 | P27487 | 3/20 | 0.35 |
| ▸ | HTT | P42858 | 2/20 | 0.34 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.34 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | FAP | Q12884 | 2/20 | 0.33 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL20986395 | 0.85 | ITGB3 (0.41) | CA1CA2CA12CA9LMNA | |
| SCHEMBL28957283 | 0.84 | ITGB3 (0.39) | CA1CA2CA12CA9LMNA | |
| SCHEMBL2730657 | 0.84 | LMNA (0.46) | CA1CA2CA12CA9EPHX1 | |
| SCHEMBL28957279 | 0.84 | ITGB3 (0.39) | CA1CA2CA12CA9LMNA | |
| SCHEMBL28813230 | 0.83 | EPHX1 (0.41) | EPHX1ALDH1A1DPP4HTTCXCR4 | |
| SCHEMBL477251 | 0.80 | DRD4 (0.40) | ALDH1A1CXCR4SMN1; SMN2 | |
| SCHEMBL2814070 | 0.79 | USP30 (0.49) | CA1CA2EPHX1ALDH1A1 | |
| SCHEMBL16824659 | 0.79 | CA1 (0.38) | CA1CA2CA12CA9LMNA | |
| SCHEMBL2729026 | 0.79 | CA1 (0.42) | CA1CA2CA12CA9LMNA | |
| SCHEMBL2240702 | 0.79 | CA1 (0.42) | CA1CA2CA12CA9LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2411387-A2 | PYRIMIDINYL AND 1,3,5-TRIAZINYL BENZIMIDAZOLE SULFONAMIDES AND THEIR USE IN CANCER THERAPY | Pathway Therapeutics, Inc. (US) | 2012-02-01 | — | — | EP | disclosed |
| WO-2010110685-A2 | PYRIMDDINYL AND 1,3,5-TRIAZINYL BENZIMTOAZOLE SULFONAMIDES AND THEIR USE IN CANCER THERAPY | PATHWAY THERAPEUTICS LIMITED (NZ) | 2010-09-30 | — | — | WO | disclosed |